Truy tìm dấu vết của XPD: vấn đề chu kỳ tế bào - làm rõ mối quan hệ kiểu gen - kiểu hình của các đột biến XPD

Lehmann AR: The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev 2001, 15: 15–23. 10.1101/gad.859501

Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, Digiovanna JJ: Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 2007, 145: 1388–1396. 10.1016/j.neuroscience.2006.12.020

Navarro CL, Cau P, Levy N: Molecular bases of progeroid syndromes. Hum Mol Genet 2006, 15 Spec No 2: R151-R161. 10.1093/hmg/ddl214

Niedernhofer LJ: Tissue-specific accelerated aging in nucleotide excision repair deficiency. Mech Ageing Dev 2008, 129: 408–415. 10.1016/j.mad.2008.04.010

Niedernhofer LJ: Tissue-specific accelerated aging in nucleotide excision repair deficiency. Mech Ageing Dev 2008, 129: 408–415. 10.1016/j.mad.2008.04.010

Kraemer KH, Lee MM, Scotto J: Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987, 123: 241–250. 10.1001/archderm.123.2.241

Masutani C, Araki M, Yamada A, Kusumoto R, Nogimori T, Maekawa T, et al.: Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J 1999, 18: 3491–3501. 10.1093/emboj/18.12.3491

Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NG, et al.: Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci USA 1997, 94: 8658–8663. 10.1073/pnas.94.16.8658

Nouspikel T: Nucleotide excision repair and neurological diseases. DNA Repair (Amst) 2008, 7: 1155–1167. 10.1016/j.dnarep.2008.03.015

van HA, Natarajan AT, Mayne LV, van Zeeland AA, Mullenders LH, Venema J: Deficient repair of the transcribed strand of active genes in Cockayne's syndrome cells. Nucleic Acids Res 1993, 21: 5890–5895. 10.1093/nar/21.25.5890

Bohr VA, Sander M, Kraemer KH: Rare diseases provide rare insights into DNA repair pathways, TFIIH, aging and cancer center. DNA Repair (Amst) 2005, 4: 293–302. 10.1016/j.dnarep.2004.09.010

Bergmann E, Egly JM: Trichothiodystrophy, a transcription syndrome. Trends Genet 2001, 17: 279–286. 10.1016/S0168-9525(01)02280-6

Botta E, Nardo T, Broughton BC, Marinoni S, Lehmann AR, Stefanini M: Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity. Am J Hum Genet 1998, 63: 1036–1048. 10.1086/302063

Itin PH, Sarasin A, Pittelkow MR: Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol 2001, 44: 891–920. 10.1067/mjd.2001.114294

Broughton BC, Berneburg M, Fawcett H, Taylor EM, Arlett CF, Nardo T, et al.: Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet 2001, 10: 2539–2547. 10.1093/hmg/10.22.2539

Meira LB, Graham JM Jr, Greenberg CR, Busch DB, Doughty AT, Ziffer DW, et al.: Manitoba aboriginal kindred with original cerebro-oculo- facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene. Am J Hum Genet 2000, 66: 1221–1228. 10.1086/302867

Rossignol M, Kolb-Cheynel I, Egly JM: Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. EMBO J 1997, 16: 1628–1637. 10.1093/emboj/16.7.1628

Drapkin R, Le RG, Cho H, Akoulitchev S, Reinberg D: Human cyclin-dependent kinase-activating kinase exists in three distinct complexes. Proc Natl Acad Sci USA 1996, 93: 6488–6493. 10.1073/pnas.93.13.6488

Larochelle S, Chen J, Knights R, Pandur J, Morcillo P, Erdjument-Bromage H, et al.: T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity. EMBO J 2001, 20: 3749–3759. 10.1093/emboj/20.14.3749

Ito S, Tan LJ, Andoh D, Narita T, Seki M, Hirano Y, et al.: MMXD, a TFIIH-independent XPD-MMS19 protein complex involved in chromosome segregation. Mol Cell 2010, 39: 632–640. 10.1016/j.molcel.2010.07.029

Marini F, Nardo T, Giannattasio M, Minuzzo M, Stefanini M, Plevani P, et al.: DNA nucleotide excision repair-dependent signaling to checkpoint activation. Proc Natl Acad Sci USA 2006, 103: 17325–17330. 10.1073/pnas.0605446103

Glover-Cutter K, Larochelle S, Erickson B, Zhang C, Shokat K, Fisher RP, et al.: TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II. Mol Cell Biol 2009, 29: 5455–5464. 10.1128/MCB.00637-09

Keriel A, Stary A, Sarasin A, Rochette-Egly C, Egly JM: XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell 2002, 109: 125–135. 10.1016/S0092-8674(02)00692-X

Sano M, Izumi Y, Helenius K, Asakura M, Rossi DJ, Xie M, et al.: Menage-a-trois 1 is critical for the transcriptional function of PPARgamma coactivator 1. Cell Metab 2007, 5: 129–142. 10.1016/j.cmet.2007.01.003

Helenius K, Yang Y, Alasaari J, Makela TP: Mat1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipocyte differentiation. Mol Cell Biol 2009, 29: 315–323. 10.1128/MCB.00347-08

Rossi DJ, Londesborough A, Korsisaari N, Pihlak A, Lehtonen E, Henkemeyer M, et al.: Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1. EMBO J 2001, 20: 2844–2856. 10.1093/emboj/20.11.2844

Coin F, Marinoni JC, Rodolfo C, Fribourg S, Pedrini AM, Egly JM: Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet 1998, 20: 184–188. 10.1038/2491

Larochelle S, Batliner J, Gamble MJ, Barboza NM, Kraybill BC, Blethrow JD, et al.: Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics. Nat Struct Mol Biol 2006, 13: 55–62. 10.1038/nsmb1028

Chen J, Larochelle S, Li X, Suter B: Xpd/Ercc2 regulates CAK activity and mitotic progression. Nature 2003, 424: 228–232. 10.1038/nature01746

Chen J, Suter B: Xpd, a structural bridge and a functional link. Cell Cycle 2003, 2: 503–506. 10.4161/cc.2.6.558

Ito S, Kuraoka I, Chymkowitch P, Compe E, Takedachi A, Ishigami C, et al.: XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol Cell 2007, 26: 231–243. 10.1016/j.molcel.2007.03.013

Dubaele S, Proietti De SL, Bienstock RJ, Keriel A, Stefanini M, Van HB, et al.: Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol Cell 2003, 11: 1635–1646. 10.1016/S1097-2765(03)00182-5

Singleton MR, Dillingham MS, Wigley DB: Structure and mechanism of helicases and nucleic acid translocases. Annu Rev Biochem 2007, 76: 23–50. 10.1146/annurev.biochem.76.052305.115300

Balajee AS, Bohr VA: Genomic heterogeneity of nucleotide excision repair. Gene 2000, 250: 15–30. 10.1016/S0378-1119(00)00172-4

Lindahl T, Wood RD: Quality control by DNA repair. Science 1999, 286: 1897–1905. 10.1126/science.286.5446.1897

McKinnon PJ: DNA repair deficiency and neurological disease. Nat Rev Neurosci 2009, 10: 100–112. 10.1038/nrn2559

Coin F, Oksenych V, Mocquet V, Groh S, Blattner C, Egly JM: Nucleotide excision repair driven by the dissociation of CAK from TFIIH. Mol Cell 2008, 31: 9–20. 10.1016/j.molcel.2008.04.024

Sandrock B, Egly JM: A yeast four-hybrid system identifies Cdk-activating kinase as a regulator of the XPD helicase, a subunit of transcription factor IIH. J Biol Chem 2001, 276: 35328–35333. 10.1074/jbc.M105570200

Tirode F, Busso D, Coin F, Egly JM: Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7. Mol Cell 1999, 3: 87–95. 10.1016/S1097-2765(00)80177-X

Makela TP, Parvin JD, Kim J, Huber LJ, Sharp PA, Weinberg RA: A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription. Proc Natl Acad Sci USA 1995, 92: 5174–5178. 10.1073/pnas.92.11.5174

Serizawa H, Conaway JW, Conaway RC: Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription. Nature 1993, 363: 371–374. 10.1038/363371a0

Larochelle S, Pandur J, Fisher RP, Salz HK, Suter B: Cdk7 is essential for mitosis and for in vivo Cdk-activating kinase activity. Genes Dev 1998, 12: 370–381. 10.1101/gad.12.3.370

Price DH: Regulation of RNA polymerase II elongation by c-Myc. Cell 2010, 141: 399–400. 10.1016/j.cell.2010.04.016

Glover-Cutter K, Kim S, Espinosa J, Bentley DL: RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes. Nat Struct Mol Biol 2008, 15: 71–78. 10.1038/nsmb1352

Schwartz BE, Larochelle S, Suter B, Lis JT: Cdk7 is required for full activation of Drosophila heat shock genes and RNA polymerase II phosphorylation in vivo. Mol Cell Biol 2003, 23: 6876–6886. 10.1128/MCB.23.19.6876-6886.2003

da Costa RM, Riou L, Paquola A, Menck CF, Sarasin A: Transcriptional profiles of unirradiated or UV-irradiated human cells expressing either the cancer-prone XPB/CS allele or the noncancer-prone XPB/TTD allele. Oncogene 2005, 24: 1359–1374. 10.1038/sj.onc.1208288

Botta E, Nardo T, Lehmann AR, Egly JM, Pedrini AM, Stefanini M: Reduced level of the repair/transcription factor TFIIH in trichothiodystrophy. Hum Mol Genet 2002, 11: 2919–2928. 10.1093/hmg/11.23.2919

Woodbury EL, Morgan DO: Cdk and APC activities limit the spindle-stabilizing function of Fin1 to anaphase. Nat Cell Biol 2007, 9: 106–112. 10.1038/ncb1523

Edgar BA: Cell cycle. Cell-cycle control in a developmental context. Curr Biol 1994, 4: 522–524. 10.1016/S0960-9822(00)00113-5

Larochelle S, Merrick KA, Terret ME, Wohlbold L, Barboza NM, Zhang C, et al.: Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol Cell 2007, 25: 839–850. 10.1016/j.molcel.2007.02.003

Edgar BA, Sprenger F, Duronio RJ, Leopold P, O'Farrell PH: Distinct molecular mechanism regulate cell cycle timing at successive stages of Drosophila embryogenesis. Genes Dev 1994, 8: 440–452. 10.1101/gad.8.4.440

Branzei D, Foiani M: Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol 2008, 9: 297–308. 10.1038/nrm2351

Lukas J, Lukas C, Bartek J: Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst) 2004, 3: 997–1007. 10.1016/j.dnarep.2004.03.006

Zhou BB, Elledge SJ: The DNA damage response: putting checkpoints in perspective. Nature 2000, 408: 433–439. 10.1038/35044005

Schumacher B, Garinis GA, Hoeijmakers JH: Age to survive: DNA damage and aging. Trends Genet 2008, 24: 77–85. 10.1016/j.tig.2007.11.004

Wu X, Shell SM, Yang Z, Zou Y: Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation. Cancer Res 2006, 66: 2997–3005. 10.1158/0008-5472.CAN-05-3403

Hwang BJ, Ford JM, Hanawalt PC, Chu G: Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci USA 1999, 96: 424–428. 10.1073/pnas.96.2.424

Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, et al.: p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet 1995, 10: 188–195. 10.1038/ng0695-188

Wang XW, Vermeulen W, Coursen JD, Gibson M, Lupold SE, Forrester K, et al.: The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev 1996, 10: 1219–1232. 10.1101/gad.10.10.1219

Ko LJ, Shieh SY, Chen X, Jayaraman L, Tamai K, Taya Y, et al.: p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol Cell Biol 1997, 17: 7220–7229.

Weber A, Liu J, Collins I, Levens D: TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression. Mol Cell Biol 2005, 25: 147–161. 10.1128/MCB.25.1.147-161.2005

Liu J, Akoulitchev S, Weber A, Ge H, Chuikov S, Libutti D, et al.: Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum. Cell 2001, 104: 353–363. 10.1016/S0092-8674(01)00223-9

Liu J, Kouzine F, Nie Z, Chung HJ, Elisha-Feil Z, Weber A, et al.: The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J 2006, 25: 2119–2130. 10.1038/sj.emboj.7601101

Vervoorts J, Luscher-Firzlaff J, Luscher B: The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem 2006, 281: 34725–34729. 10.1074/jbc.R600017200

Cotter TG: Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009, 9: 501–507. 10.1038/nrc2663

Cowling VH, Cole MD: HATs off to capping: a new mechanism for Myc. Cell Cycle 2007, 6: 907–909. 10.4161/cc.6.21.4880

Cowling VH, Cole MD: The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Mol Cell Biol 2007, 27: 2059–2073. 10.1128/MCB.01828-06

Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, et al.: Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 2001, 3: 392–399. 10.1038/35070076

Bootsma D, Hoeijmakers JH: DNA repair. Engagement with transcription. Nature 1993, 363: 114–115. 10.1038/363114a0

de WH, de WJ, Andressoo JO, van Oostrom CT, Riis B, Weimann A, et al.: Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage. Mol Cell Biol 2004, 24: 7941–7948. 10.1128/MCB.24.15.6850-6860.2004

Lehmann AR, Niimi A, Ogi T, Brown S, Sabbioneda S, Wing JF, et al.: Translesion synthesis: Y-family polymerases and the polymerase switch. DNA Repair (Amst) 2007, 6: 891–899. 10.1016/j.dnarep.2007.02.003

Boyle J, Ueda T, Oh KS, Imoto K, Tamura D, Jagdeo J, et al.: Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy. Hum Mutat 2008, 29: 1194–1208. 10.1002/humu.20768

Berneburg M, Lowe JE, Nardo T, Araujo S, Fousteri MI, Green MH, et al.: UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome. EMBO J 2000, 19: 1157–1166. 10.1093/emboj/19.5.1157

Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih I, Vogelstein B, et al.: The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 2002, 99: 16226–16231. 10.1073/pnas.202617399

Garinis GA, van der Horst GT, Vijg J, Hoeijmakers JH: DNA damage and ageing: new-age ideas for an age-old problem. Nat Cell Biol 2008, 10: 1241–1247. 10.1038/ncb1108-1241

Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, et al.: Genomic instability in laminopathy-based premature aging. Nat Med 2005, 11: 780–785. 10.1038/nm1266

Campisi J: Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120: 513–522. 10.1016/j.cell.2005.02.003

Chen D, Riedl T, Washbrook E, Pace PE, Coombes RC, Egly JM, et al.: Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell 2000, 6: 127–137. 10.1016/S1097-2765(00)00014-9

Campbell RM, Digiovanna JJ: Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients. Dermatol Ther 2006, 19: 306–314. 10.1111/j.1529-8019.2006.00088.x

Benhamou S, Sarasin A: ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 2002, 17: 463–469. 10.1093/mutage/17.6.463

Compe E, Malerba M, Soler L, Marescaux J, Borrelli E, Egly JM: Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH. Nat Neurosci 2007, 10: 1414–1422. 10.1038/nn1990

Moodycliffe AM, Nghiem D, Clydesdale G, Ullrich SE: Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000, 1: 521–525. 10.1038/82782

Lehmann AR, Norris PG: DNA repair and cancer: speculations based on studies with xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy. Carcinogenesis 1989, 10: 1353–1356. 10.1093/carcin/10.8.1353

Norris PG, Limb GA, Hamblin AS, Hawk JL: Impairment of natural-killer-cell activity in xeroderma pigmentosum. N Engl J Med 1988, 319: 1668–1669. 10.1056/NEJM198812223192512

Gaspari AA, Fleisher TA, Kraemer KH: Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest 1993, 92: 1135–1142. 10.1172/JCI116682

Mariani E, Facchini A, Honorati MC, Lalli E, Berardesca E, Ghetti P, et al.: Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy. Clin Exp Immunol 1992, 88: 376–382. 10.1111/j.1365-2249.1992.tb06457.x

Gasser S, Raulet D: The DNA damage response, immunity and cancer. Semin Cancer Biol 2006, 16: 344–347. 10.1016/j.semcancer.2006.07.004

Andressoo JO, Mitchell JR, de WJ, Hoogstraten D, Volker M, Toussaint W, et al.: An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria. Cancer Cell 2006, 10: 121–132. 10.1016/j.ccr.2006.05.027

Itoh M, Hayashi M, Shioda K, Minagawa M, Isa F, Tamagawa K, et al.: Neurodegeneration in hereditary nucleotide repair disorders. Brain Dev 1999, 21: 326–333. 10.1016/S0387-7604(99)00033-9

Brooks PJ, Cheng TF, Cooper L: Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage? DNA Repair (Amst) 2008, 7: 834–848. 10.1016/j.dnarep.2008.01.017

Anolik JH, Di Giovanna JJ, Gaspari AA: Effect of isotretinoin therapy on natural killer cell activity in patients with xeroderma pigmentosum. Br J Dermatol 1998, 138: 236–241. 10.1046/j.1365-2133.1998.02067.x

Cleaver JE, Thompson LH, Richardson AS, States JC: A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum Mutat 1999, 14: 9–22. 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.0.CO;2-6